SyncThink announces the receipt of its 12th patent for its EYE-SYNC technology. US patent 14/530,598 allows SyncThing to use system and methods for creating and changing dynamic content based on eye gaze analysis.
Research teams in Madrid, Spain, and Toronto, Canada, respectively, are using focused ultrasound technology to target a new area of the brain in patients with Parkinson's disease and potentially curb, or even reverse, its progression, according to a news release.
A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor (ET) or Parkinson's disease (PD) tremor, according to a new study being presented at the annual meeting of the Radiological Society of North America (RSNA).
Scott Anderson, formerly the athletic director at Stanford University, joins SyncThink as chief customer officer. In addition, SyncThink opens a permanent office in Palo Alto, Calif.
Valencia, Calif-based Bioness Inc reports that its L300 Go System, which received FDA clearance in January, has now received the CE Mark in the European Union.
SpeedMaker introduces NewGait, described as a tool for physical therapists to use in clinics and for patients with paraplegia who experience bilateral dorsiflexor and quadricep weakness.
The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a recent study in Neurology, the medical journal of the American Academy of Neurology.
Patient-centered care, a multi-disciplinary team, and technology play key roles in getting the best results. A feature for the June/July 2019 issue of Physical Therapy Products magazine by Kelley Limbauan, PT, DPT.
People with Parkinson's disease who participate in a special, non-contact boxing program may have better quality of life and be more likely to exercise than those who do not participate, according to a recent study.